Literature DB >> 30190867

What are the therapeutic implications of increased collagen expression in melanoma cells treated with vemurafenib?

Constance E Brinckerhoff1.   

Abstract

Entities:  

Keywords:  BRAFV600E; BRAFWT; MAPK signaling; MEK inhibitors; TGF-β; carcinoma-activated fibroblasts; fibroblasts; tumor microenvironment; vemurafenib/PLX4032

Year:  2016        PMID: 30190867      PMCID: PMC6094651          DOI: 10.2217/mmt.15.36

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


× No keyword cloud information.
  20 in total

1.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.

Authors:  Benjamin Diop-Frimpong; Vikash P Chauhan; Stephen Krane; Yves Boucher; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 2.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

Review 3.  Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options.

Authors:  Jessie Villanueva; Adina Vultur; Meenhard Herlyn
Journal:  Cancer Res       Date:  2011-12-01       Impact factor: 12.701

4.  Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1.

Authors:  P Henriet; Z D Zhong; P C Brooks; K I Weinberg; Y A DeClerck
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner.

Authors:  Eric W Joseph; Christine A Pratilas; Poulikos I Poulikakos; Madhavi Tadi; Weiqing Wang; Barry S Taylor; Ensar Halilovic; Yogindra Persaud; Feng Xing; Agnes Viale; James Tsai; Paul B Chapman; Gideon Bollag; David B Solit; Neal Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

6.  TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.

Authors:  Miao Yin; Johanna Soikkeli; Tiina Jahkola; Susanna Virolainen; Olli Saksela; Erkki Hölttä
Journal:  Am J Pathol       Date:  2012-10-10       Impact factor: 4.307

7.  Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.

Authors:  Léon C L T van Kempen; Jos Rijntjes; Ine Mamor-Cornelissen; Silvia Vincent-Naulleau; Marie-Jeanne P Gerritsen; Dirk J Ruiter; Marcory C R F van Dijk; Claudine Geffrotin; Goos N P van Muijen
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

8.  Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.

Authors:  Leisl M Packer; Philip East; Jorge S Reis-Filho; Richard Marais
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-04       Impact factor: 4.693

Review 9.  The extracellular matrix: a dynamic niche in cancer progression.

Authors:  Pengfei Lu; Valerie M Weaver; Zena Werb
Journal:  J Cell Biol       Date:  2012-02-20       Impact factor: 10.539

10.  BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity.

Authors:  C A Whipple; C E Brinckerhoff
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.